These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 28950022

  • 1. Validation of participant eligibility for pre-exposure prophylaxis: Baseline data from the PRELUDE demonstration project.
    Vaccher SJ, Grulich AE, Haire BG, Conway DP, Poynten IM, Ooi C, Foster R, Templeton DJ, Zablotska IB, PRELUDE Study Team.
    PLoS One; 2017; 12(9):e0185398. PubMed ID: 28950022
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Willingness to use and have sex with men taking HIV pre-exposure prophylaxis (PrEP): results of online surveys of Australian gay and bisexual men, 2011-2015.
    Holt M, Lea T, Schmidt HM, Kolstee J, Ellard J, Murphy D, Truong HH, de Wit J.
    Sex Transm Infect; 2017 Sep; 93(6):438-444. PubMed ID: 28108701
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study.
    Grulich AE, Guy R, Amin J, Jin F, Selvey C, Holden J, Schmidt HA, Zablotska I, Price K, Whittaker B, Chant K, Cooper C, McGill S, Telfer B, Yeung B, Levitt G, Ogilvie EE, Dharan NJ, Hammoud MA, Vaccher S, Watchirs-Smith L, McNulty A, Smith DJ, Allen DM, Baker D, Bloch M, Bopage RI, Brown K, Carr A, Carmody CJ, Collins KL, Finlayson R, Foster R, Jackson EY, Lewis DA, Lusk J, O'Connor CC, Ryder N, Vlahakis E, Read P, Cooper DA, Expanded PrEP Implementation in Communities New South Wales (EPIC-NSW) research group.
    Lancet HIV; 2018 Nov; 5(11):e629-e637. PubMed ID: 30343026
    [Abstract] [Full Text] [Related]

  • 9. NZPrEP Demonstration Project: protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) to determine feasibility, acceptability, adverse and behavioural effects of PrEP provision to gay and bisexual men in publicly funded sexual health clinics in Auckland, New Zealand.
    Azariah S, Saxton P, Franklin R, Forster R, Werder S, Jenkins R.
    BMJ Open; 2019 Jun 27; 9(6):e026363. PubMed ID: 31248921
    [Abstract] [Full Text] [Related]

  • 10. Baseline characteristics of gay and bisexual men in a HIV pre-exposure prophylaxis demonstration project with equity quotas in Auckland, New Zealand.
    Saxton PJW, Azariah S, Franklin RA, Forster RF, Werder SF, Jenkins R, Myers JM, Rich JG, Te Wake WP, Fisher MD.
    Sex Health; 2019 Feb 27; 16(1):47-55. PubMed ID: 30274568
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increases in HIV Testing Frequency in Australian Gay and Bisexual Men are Concentrated Among PrEP Users: An Analysis of Australian Behavioural Surveillance Data, 2013-2018.
    Bavinton BR, Grulich AE, Broady T, Keen P, Mao L, Patel P, Chan C, Prestage GP, Holt M.
    AIDS Behav; 2020 Sep 27; 24(9):2691-2702. PubMed ID: 32162094
    [Abstract] [Full Text] [Related]

  • 18. Use of HIV Pre-exposure Prophylaxis (PrEP) Associated With Lower HIV Anxiety Among Gay and Bisexual Men in Australia Who Are at High Risk of HIV Infection: Results From the Flux Study.
    Keen P, Hammoud MA, Bourne A, Bavinton BR, Holt M, Vaccher S, Haire B, Saxton P, Jin F, Maher L, Grulich AE, Prestage G.
    J Acquir Immune Defic Syndr; 2020 Feb 01; 83(2):119-125. PubMed ID: 31935203
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.